Emily Hopewell is the Director of Cell and Gene Therapy Manufacturing and an Assistant Professor in Clinical Medical and Molecular Genetics at Indiana University. She has over a decade of cellular therapy and laboratory experience. She received her PhD in Cancer Biology from the University of South Florida in 2012. She started her career as a Cell Therapy Technologist at the Moffitt Cancer in 2003. After completing her PhD in Cancer Biology at the University of South Florida in 2012, she returned to the Moffitt Cancer Center Cell Therapy Facility as a Development Specialist and then Assistant Technical Director. She has extensive experience with both standard of care stem cell therapy, as well as the next generation of cell and gene therapy, including contract manufacturing and regulatory compliance.
Emily joined Indiana University in 2018 and is charged with growing existing and implementing new manufacturing for Cell, Gene and Immune Therapy at IU. Cell and Gene Therapy Manufacturing includes Vector Production, led by Daniela Bischof, Cell Immunotherapy and Transduction, led by Vicki Graves, and Bioprocess Development, led by Matthew Welty. These three areas are supported by a Quality Assurance team, a Finance Manager, and a Logistics and Operations team, responsible for clean room facility upkeep, equipment upkeep, and inventory management.